Groowe Groowe BETA

US Stock Market News

Stay on top of the US stock market with real-time breaking news and market-moving stories. Our platform continuously aggregates updates from trusted financial news sources, giving traders and investors a fast overview of events that may impact stock prices.

Whether you're tracking specific companies or scanning the broader market, the news feed helps you quickly identify important developments as they happen.

Create an account to access the live news feed. Access is free while the platform is in beta. Visitors without an account can still browse the latest headlines with a 15-minute delay.

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Denison Reports Financial and Operational Results for Q1 2026, Highlighted by Commencement of Site Preparation and Early Works for the Phoenix ISR Uranium Mine, and the Results of its Shareholder Meeting

prnewswire.com
DNN

ROSEN, SKILLED INVESTOR COUNSEL, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX

accessnewswire.com
IBRX

CALIFORNIA SCIENCE CENTER INSTALLS THE KOREAN AIR 747 EXPERIENCE IN THE FUTURE SAMUEL OSCHIN AIR AND SPACE CENTER

prnewswire.com
DAL

ATARA DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Atara Biotherapeutics, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ATRA

accessnewswire.com
ATRA

SRS Distribution concluye la adquisición del distribuidor mayorista de HVAC Mingledorff's USA - español USA - English

prnewswire.com
HD

NMI Holdings, Inc. to Participate in Upcoming Investor Conferences

globenewswire.com
NMIH

QIAGEN N.V. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

businesswire.com
QGEN

ALIGHT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Alight, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 15 Deadline in Securities Class Action - ALIT

accessnewswire.com
ALIT

ERASCA, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

businesswire.com
ERAS

Kelun-Biotech Receives Investigational New Drug Approval from CDE for SKB118, a PD-1 x VEGF Bispecific Antibody USA - English APAC - Traditional Chinese APAC - English

prnewswire.com
CRBP
View all news →